Neuroprotective effects of roflumilast against quinolinic acid-induced rat model of Huntington’s disease through inhibition of NF-κB mediated neuroinflammatory markers and activation of cAMP/CREB/BDNF signaling pathway
Keyword(s):
2003 ◽
Vol 183
(2)
◽
pp. 700-704
◽
Keyword(s):
Keyword(s):
2018 ◽
Vol 828
◽
pp. 31-41
◽
Keyword(s):
2004 ◽
Vol 152
(2)
◽
pp. 375-383
◽
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):